Tissue factor and factor V involvement in rat peritoneal fibrosis

Peritoneal Dialysis International

Volumn 29, Issue 3, 2009, Pages 340-351

  Saito, Hiroki ^a   Kitamoto, Masayuki ^a   Kato, Kozue ^a   Liu, Ning ^a   Kitamura, Hisayo ^a   Uemura, Kazuhide ^a   Nogaki, Fumiaki ^b   Takeda, Toshiya ^c   Mori, Noriko ^d   Ono, Takahiko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Shimada Municipal Hospital   (Japan)

^c Kyoto Takeda Hospital   (Japan)

^d SHIZUOKA GENERAL HOSPITAL   (Japan)

Author keywords

Encapsulating peritoneal sclerosis; Factor X; Fibrin; PAR2; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; CD31 ANTIGEN; CHLORHEXIDINE GLUCONATE; COLLAGEN TYPE 5; FIBRIN; FIBRONECTIN; FONDAPARINUX; MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE FUNCTION; MALE; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; WISTAR RAT;

EID: 67649304485     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900320     Document Type: Article

References (39)

1. Burkart JM. Peritoneal dialysis. In: Brenner BM, ed. Brenner and Rector's The Kidney. 6th ed. Philadelphia: W.B. Saunders Company; 2000: vol 2:2454-517.
2. Afthentopoulos IE, Passadakis P, Oreopoulos DG. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature. Adv Ren Replace Ther 1998; 5:157-67.
3. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140:1201-3.
4. Coles GA, Topley N. Long-term peritoneal membrane changes. Adv Ren Replace Ther 2000; 7:289-301.
5. Imai H, Nakamoto H, Fucshima R, Yamanouchi Y, Ishida Y, Suzuki H. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis. Adv Perit Dial 2002; 18:124-30.
6. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S39-47.
7. Honda K, Oda H. Pathology of encapsulating peritoneal sclerosis. Perit Dial Int 2005; 25(Suppl 4):S19-29.
8. Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, et al. Preventive effect of pirfenidone against experimental sclerosing peritonitis on rats. Exp Toxic Pathol 1995; 47:287-91.
9. Ishii Y, Sawada T, Shimizu A, Tojimbara T, Nakajima I, Fuchinoue S, et al. An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 2001; 16:1262-6.
10. Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, et al. Enhanced expression of heat shock protein 47 (HSP47) in rat model of peritoneal fibrosis. Perit Dial Int 2003; 23:14-22.
11. Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T, et al. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 2003; 64:887-96.
12. Okada H, Inoue T, Kanno Y, Kobayashi T, Watanabe Y, Ban S, et al. Selective depletion of fibroblasts preserves morphology and the functional integrity of peritoneum in transgenic mice with peritoneal fibrosing syndrome. Kidney Int 2003; 64:1722-32.
13. Kane WH, Ichinose A, Hagen FS, Davie EW. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry 1987; 26: 6508-14.
14. Mann KG, Jenny RJ, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem 1988; 57:915-56.
15. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53: 245-82.
16. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84:579-621.
17. Liu N, Makino T, Nogaki F, Kusano H, Suyama K, Muso E, et al. Coagulation in the mesangial area promotes extracellular matrix accumulation through factor V expression in MsPGN in rats. Am J Physiol Renal Physiol 2004; 287: F612-F620.
18. Frank RD, Schabbauer G, Holscher T, Sato Y, Tencati M, Pawlinski R, et al. The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury. J Thromb Haemost 2005; 3:531-40.
19. Ro Y, Hamada C, Inaba M, Io H, Kaneko K, Tomino Y. Inhibitory effects of matrix metalloproteinase inhibitor ONO-4817 on morphological alterations in chlorhexidine gluconate-induced peritoneal sclerosis rats. Nephrol Dial Transplant 2007; 22:2838-48.
20. Ono T, Liu N, Kasuno K, Kusano H, Nogaki F, Kamata T, et al. Coagulation process proceeds on cultured human mesangial cells via expression of factor V. Kidney Int 2001; 60: 1009-17.
21. Arai A, Hirano H, Ueta Y, Hamada T, Mita T, Shirahata A. Detection of mononuclear cells as the source of the increased tissue factor mRNA in the liver from lipopolysaccharide-treated rats. Thromb Res 2000; 97:153-62.
22. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17:2484-94.
23. Mateijsen MA, van der Wal AC, Hendriks PM, Zweers MM, Mulder J, Struijk DG, et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19:517-25.
24. Io H, Hamada C, Ro Y, Ito Y, Hirahara I, Tomino Y. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int 2004; 65:1927-36.
25. Yoshio Y, Miyazaki M, Abe K, Nishino T, Furusu A, Mizuta Y, et al. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model. Kidney Int 2004; 66:1677-85.
26. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, et al. Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int 2000; 58: 598-606.
27. Liu N, Mori N, Iehara N, Uemura K, Fukastu A, Kita T, et al. Soluble fibrin formation in the mesangial area of IgA nephropathy. Clin Exp Nephrol 2007; 11:71-6.
28. Ono T, Muso E, Suyama K, Oyama A, Matsushima H, Yashiro M, et al. Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch-Schönlein purpura nephritis. Nephron 1996; 74:522-8.
29. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, et al. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 2004; 109:2001-8.
30. Hart PH, Jones CA, Finlay-Jones JJ. Peritoneal macrophages during peritonitis. Phenotypic studies. Clin Exp Immunol 1992; 88:484-91.
31. Lindahl U, Pejler G, Bogwald J, Seljelid R. A prothrombinase complex of mouse peritoneal macrophages. Arch Biochem Biophys 1989; 273:180-8.
32. Aroeira LS, Aguilera A, Sánchez-Tomero JA, Bajo MA, del Peso G, Jiménez-Heffernan JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol 2007; 18:2004-13.
33. Grand RJ, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313(Pt 2):353-68.
34. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000; 407:258-64.
35. Dugina TN, Kiseleva EV, Chistov IV, Umarova BA, Strukova SM. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Mosc) 2002; 67:65-74.
36. Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, et al. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation 2001; 72: 1437-43.
37. Grandaliano G, Pontrelli P, Cerullo G, Monno R, Ranieri E, Ursi M, et al. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. J Am Soc Nephrol 2003; 14:2072-83.
38. Mutsaers SE, Whitaker D, Papadimitriou JM. Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model. Am J Pathol 2002; 160:681-92.
39. Szaba FM, Smiley ST. Roles for thrombin and fibrin(ogen) in cytokine/ chemokine production and macrophage adhesion in vivo. Blood 2002; 99:1053-9.